290.53
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VEEV Giù?
Forum
Previsione
Precedente Chiudi:
$286.01
Aprire:
$286.71
Volume 24 ore:
75,512
Relative Volume:
0.05
Capitalizzazione di mercato:
$47.49B
Reddito:
$2.86B
Utile/perdita netta:
$780.66M
Rapporto P/E:
61.55
EPS:
4.72
Flusso di cassa netto:
$1.20B
1 W Prestazione:
+4.91%
1M Prestazione:
+2.98%
6M Prestazione:
+29.82%
1 anno Prestazione:
+57.41%
Veeva Systems Inc Stock (VEEV) Company Profile
Nome
Veeva Systems Inc
Settore
Industria
Telefono
925-452-6500
Indirizzo
4280 HACIENDA DRIVE, PLEASANTON, CA
Confronta VEEV con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
VEEV
Veeva Systems Inc
|
290.60 | 46.61B | 2.86B | 780.66M | 1.20B | 4.72 |
![]()
TEM
Tempus Ai Inc
|
65.30 | 10.57B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
HQY
Healthequity Inc
|
96.96 | 8.42B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
DOCS
Doximity Inc
|
60.99 | 11.13B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
WAY
Waystar Holding Corp
|
38.44 | 6.33B | 906.14M | -52.62M | 89.62M | -0.3621 |
Veeva Systems Inc Stock (VEEV) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-05-29 | Reiterato | Needham | Buy |
2025-01-23 | Downgrade | Goldman | Buy → Sell |
2024-12-20 | Iniziato | Stephens | Overweight |
2024-12-04 | Iniziato | Mizuho | Outperform |
2024-11-19 | Iniziato | Scotiabank | Sector Perform |
2024-10-08 | Iniziato | Exane BNP Paribas | Outperform |
2024-08-27 | Reiterato | Citigroup | Buy |
2024-07-09 | Iniziato | BTIG Research | Buy |
2023-10-25 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2023-10-13 | Iniziato | Jefferies | Buy |
2023-06-28 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
2023-06-01 | Aggiornamento | Guggenheim | Neutral → Buy |
2023-03-17 | Downgrade | Truist | Buy → Hold |
2023-02-23 | Downgrade | Guggenheim | Buy → Neutral |
2023-01-04 | Aggiornamento | Barclays | Equal Weight → Overweight |
2022-12-06 | Iniziato | Cowen | Market Perform |
2022-12-02 | Reiterato | Needham | Buy |
2022-10-31 | Iniziato | Wells Fargo | Equal Weight |
2022-10-19 | Aggiornamento | JP Morgan | Underweight → Neutral |
2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
2022-07-27 | Iniziato | Oppenheimer | Outperform |
2022-06-23 | Iniziato | Goldman | Buy |
2022-06-21 | Ripresa | Guggenheim | Buy |
2022-03-03 | Downgrade | BofA Securities | Buy → Neutral |
2022-01-28 | Iniziato | Truist | Buy |
2022-01-07 | Downgrade | Stephens | Overweight → Equal-Weight |
2022-01-06 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
2021-12-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2021-10-01 | Ripresa | Stifel | Buy |
2021-09-02 | Reiterato | BofA Securities | Buy |
2021-09-02 | Reiterato | JMP Securities | Mkt Outperform |
2021-09-02 | Reiterato | Needham | Buy |
2021-09-02 | Reiterato | UBS | Neutral |
2021-07-21 | Iniziato | Cowen | Outperform |
2021-03-31 | Aggiornamento | UBS | Sell → Neutral |
2021-01-07 | Ripresa | KeyBanc Capital Markets | Overweight |
2020-12-09 | Downgrade | JP Morgan | Neutral → Underweight |
2020-10-14 | Ripresa | UBS | Sell |
2020-08-28 | Reiterato | Needham | Buy |
2020-07-23 | Iniziato | FBN Securities | Outperform |
2020-07-07 | Iniziato | Stephens | Overweight |
2020-06-08 | Iniziato | Citigroup | Buy |
2020-05-29 | Reiterato | Needham | Buy |
2020-04-13 | Iniziato | SVB Leerink | Mkt Perform |
2020-02-19 | Iniziato | Robert W. Baird | Outperform |
2020-02-14 | Iniziato | Piper Sandler | Overweight |
2020-01-13 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2019-11-27 | Reiterato | Canaccord Genuity | Hold |
2019-09-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2019-08-28 | Reiterato | Needham | Buy |
2019-06-07 | Iniziato | Goldman | Neutral |
2019-05-30 | Reiterato | BofA/Merrill | Buy |
2019-05-30 | Aggiornamento | Stephens | Equal-Weight → Overweight |
2019-05-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2019-04-17 | Reiterato | Needham | Buy |
2019-02-27 | Reiterato | Needham | Buy |
Mostra tutto
Veeva Systems Inc Borsa (VEEV) Ultime notizie
Veeva Systems Inc. Stock Analysis and ForecastMarket-crushing profits - Autocar Professional
What drives Veeva Systems Inc. stock priceOutstanding trading profits - Autocar Professional
Speed, Scale, and Connectivity: Teva’s New Standard for Medical Information - Veeva
Is Veeva Systems Inc. a good long term investmentMarket-beating performance - Autocar Professional
What analysts say about Veeva Systems Inc. stockTurbocharged investment results - jammulinksnews.com
Veeva Vs. Salesforce: Which Life Sciences CRM Stock Is The Better Buy? - Barchart.com
Veeva vs. Salesforce: Which Life Sciences CRM Stock Is the Better Buy? - Yahoo Finance
Boehringer Ingelheim adopts Veeva data solutions across 100+ countries By Investing.com - Investing.com Canada
Veeva OpenData and Veeva Network Enable Coordinated Customer Engagement for Boehringer Ingelheim - Financial Times
Veeva Systems (VEEV) Gets a Buy from Raymond James - The Globe and Mail
Best Statistical Healthcare Participant Recruitment - openPR.com
Veeva Announces Merck's Commitment to Veeva Vault CRM - AInvest
Veeva Vault CRM Gains Momentum with Top Pharma Companies Committing to Migration - AInvest
Veeva's Break from Salesforce: A Strategic Inflection Point for Life Sciences SaaS - AInvest
Veeva Systems (VEEV) Secures Merck Commitment To Enhance Global CRM Capabilities - Yahoo Finance
Veeva Systems Breaks Up With Salesforce, Then Woos Merck - Investor's Business Daily
Merck Adopts Veeva Vault CRM - Contract Pharma
Merck Commits To Veeva’s Vault CRM, Draws Wall Street Cheer: Retail’s Not Enthusiastic - Stocktwits
Merck (MRK) Expands Partnership with Veeva Systems for Enhanced CRM Solutions | MRK Stock News - GuruFocus
Merck Commits to Veeva Vault CRM | VEEV Stock News - GuruFocus
Merck commits to Veeva Vault CRM for upcoming product launches - Investing.com India
Veeva announces Merck committed to Veeva Vault CRM - TipRanks
Merck commits to Veeva Vault CRM for upcoming product launches By Investing.com - Investing.com UK
Merck Commits to Veeva Vault CRM - Veeva
Merck commits to Veeva Vault CRM for commercial execution. - AInvest
Merck Expands Veeva Partnership: Strategic CRM Deal Ahead of Largest Launch Period in History - Stock Titan
Smith+Nephew: Unpacking the Critical Roles of Clinical and Medical Affairs - Veeva
Veeva Systems Trading Volume Surges 68.79% to 348th Position Despite Stock Price Decline - AInvest
Veeva Systems (VEEV) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
IBD Stock Of The Day Veeva Systems Is Gearing Up To Take On Salesforce - Investor's Business Daily
Why Veeva Systems Outpaces Salesforce in a Fragmented CRM Market - AInvest
Veeva Systems (NYSE:VEEV) Price Target Raised to $325.00 - MarketBeat
Veeva Systems' Vault CRM Continues to Gain Momentum with Top Biopharma Adoptions and New Features - AInvest
Veeva Systems' Vault CRM Momentum Builds With Top Biopharma Adoptions - Yahoo Finance
Veeva (VEEV) Expands with Astellas and Sarah Cannon in Global CRM and Oncology Trials - MSN
Veeva Systems and Sarah Cannon Partner to Accelerate Cancer Clinical Trials - MSN
Fresenius Medical Care Reduces Commercial Content Approval by 14 Days - Veeva
Should You Invest in Veeva (VEEV) Based on Bullish Wall Street Views? - Yahoo Finance
Clinical Data Management Systems Market Key Players Analysis - openPR.com
Veeva Systems Trading Volume Drops 38 Percent to 338th Rank Despite Stock Price Rise - AInvest
Why Veeva Systems (VEEV) is a Top Growth Stock for the Long-Term - Yahoo Finance
Veeva Systems (NYSE:VEEV): Strongest Q1 Results from the Vertical Software Group - Yahoo Finance
Veeva Systems (VEEV) Suffers a Larger Drop Than the General Market: Key Insights - MSN
12 Best Cloud Stocks to Buy According to Wall Street Analysts - Insider Monkey
Veeva Systems Surges to 185th in Trading Volume with $451 Million Day Despite Stock Decline - AInvest
Veeva Systems Inc Azioni (VEEV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):